Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Acquisitions & DivestmentsChange in CashDeferred TaxesDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Teva Pharmaceutical Industries (TEVJF) Acquisitions (2016 - 2024)

Historic Acquisitions for Teva Pharmaceutical Industries (TEVJF) over the last 9 years, with Q4 2024 value amounting to -$30.0 million.

  • Teva Pharmaceutical Industries' Acquisitions changed N/A to -$30.0 million in Q4 2024 from the same period last year, while for Sep 2025 it was -$30.0 million, marking a year-over-year decrease of 30000.0%. This contributed to the annual value of -$15.0 million for FY2024, which is N/A changed from last year.
  • As of Q4 2024, Teva Pharmaceutical Industries' Acquisitions stood at -$30.0 million.
  • In the past 5 years, Teva Pharmaceutical Industries' Acquisitions ranged from a high of $15.0 million in Q1 2024 and a low of -$30.0 million during Q4 2024